株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国における心臓補助装置市場の見通し

United States Cardiac Assist Devices Market Outlook to 2025

発行 GlobalData 商品コード 302393
出版日 ページ情報 英文 59 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.48円で換算しております。
Back to Top
米国における心臓補助装置市場の見通し United States Cardiac Assist Devices Market Outlook to 2025
出版日: 2018年04月01日 ページ情報: 英文 59 Pages
概要

当レポートでは、米国における心臓補助装置市場について、大動脈内バルーンポンプ(IABP)、完全置換型人工心臓、および心室補助装置のカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • 心臓補助装置市場の区分
  • 本レポートで対象としている市場の定義

第3章 米国における心臓補助装置市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 主要企業の概要

  • Thoratec Corporation
  • Maquet Holding B.V. & Co. KG.
  • HeartWare International, Inc.
  • Teleflex Incorporated
  • SynCardia Systems, Inc.
  • Berlin Heart GmbH
  • Abiomed, Inc.

第5章 パイプライン製品

第6章 財務取引の情勢

  • 社債発行
  • 株式発行
  • 提携
  • プライベート・エクイティ
  • ベンチャー資金調達

第7章 最近の動向

  • コーポレート・コミュニケーション
  • 財務発表
  • 政府および公益関連
  • 法規制
  • 他の重要な動き
  • 製品情報

第8章 付録

図表

目次
Product Code: GDMECC2971DB

GlobalData's new report, "United States Cardiac Assist Devices Market Outlook to 2025", provides key market data on the United States Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cardiac Assist Devices market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiac Assist Devices market.
  • Global corporate-level profiles of key companies operating within the United States Cardiac Assist Devices market.
  • Key players covered include Abbott Laboratories, Medtronic plc, Getinge AB. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 What Is This Report About? 5
  • 2.2 Cardiac assist devices Market Segmentation 5
  • 2.3 Definitions of Markets Covered in the Report 6

3 Cardiac Assist Devices Market, United States 8

  • 3.1 Cardiac Assist Devices Market, United States, Revenue ($m), 2015-2025 8
    • 3.1.1 Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), by Segment, 2015-2025 10
    • 3.1.2 Ventricular Assist Devices Market, United States, Revenue ($m), by Segment, 2015-2025 12
  • 3.2 Cardiac Assist Devices Market, United States, Volume (Units), 2015-2025 15
    • 3.2.1 Intra-Aortic Balloon Pumps Market, United States, Volume (Units), by Segment, 2015-2025 17
    • 3.2.2 Ventricular Assist Devices Market, United States, Volume (Units), by Segment, 2015-2025 19
  • 3.3 Cardiac Assist Devices Market, United States, Average Price ($), 2015-2025 22
  • 3.4 Cardiac Assist Devices Market, United States, Distribution Share by Revenue ($m), 2017 24
  • 3.5 Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), 2017 25

4 Overview of Key Companies in United States, Cardiac Assist Devices Market 27

  • 4.1 Abbott Laboratories 27
    • 4.1.1 Company Overview 27
  • 4.2 Medtronic Plc 27
    • 4.2.1 Company Overview 27
  • 4.3 Getinge AB 27
    • 4.3.1 Company Overview 27
  • 4.4 Teleflex Inc 27
    • 4.4.1 Company Overview 27
  • 4.5 Syncardia Systems LLC 28
    • 4.5.1 Company Overview 28

5 Cardiac Assist Devices Market Pipeline Products 29

6 Financial Deals Landscape 30

  • 6.1 Private Equity 30
    • 6.1.1 Audax Private Equity Acquires Belmont Instrument 30
  • 6.2 Venture Financing 31
    • 6.2.1 Ariste Medical Raises USD0.3 Million in Financing 31

7 Recent Developments 32

  • 7.1 Corporate Communications 32
    • 7.1.1 Jan 10, 2018: Ventripoint Appoints Head of Sales for North America 32
    • 7.1.2 Dec 19, 2017: Ventripoint Diagnostics Provides Corporate Update 32
    • 7.1.3 Dec 08, 2017: Micron Solutions Designates Mr. E. P. Marinos as a Director Emeritus and Appoints Mr. Andrei Soran to its Board of Directors 33
    • 7.1.4 Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 34
    • 7.1.5 Jul 24, 2017: Micron Solutions Appoints Rodd E. Friedman to its Board of Directors 34
    • 7.1.6 Jul 20, 2017: A Third Highly Successful Ultrasound Executive joins Ventripoint 34
    • 7.1.7 Jun 21, 2017: Highly Successful Global Industry Sales & Marketing Executives Hired by Ventripoint 35
  • 7.2 Financial Announcements 36
    • 7.2.1 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 36
    • 7.2.2 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 36
    • 7.2.3 Nov 13, 2017: Micron Solutions Reports 2017 Third Quarter Results 37
    • 7.2.4 Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 38
    • 7.2.5 Oct 23, 2017: REVA to Present Fantom 24-Month Data at TCT 2017 39
    • 7.2.6 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference 40
    • 7.2.7 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine 41
    • 7.2.8 Aug 11, 2017: Micron Solutions Reports 2017 Second Quarter Results 43
    • 7.2.9 Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 45
    • 7.2.10 May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 46
  • 7.3 Product News 47
    • 7.3.1 Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 47
    • 7.3.2 Nov 27, 2017: Ventripoint Invents a New Way to Track Ultrasound Probes That Will Speed up Exams 48
    • 7.3.3 Oct 19, 2017: Abiomed's Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations 48
    • 7.3.4 Jun 09, 2017: Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology 49
    • 7.3.5 Jun 01, 2017: Medical Device Company TandemLife Set to Simplify Life Support 49
  • 7.4 Strategy And Business Planning 50
    • 7.4.1 Nov 20, 2017: DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients 50
    • 7.4.2 Mar 30, 2017: Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts 51

8 Appendix 53

  • 8.1 Research Methodology 54
    • 8.1.1 Coverage 54
    • 8.1.2 Secondary Research 54
    • 8.1.3 Primary Research 55
    • 8.1.4 Market Modeling and Forecasting 56
    • 8.1.5 Company Share Analysis 57
    • 8.1.6 Distribution Share Analysis 58
    • 8.1.7 Benchmarking 58
  • 8.2 GlobalData Consulting 58
  • 8.3 Contact Us 59
  • 8.4 Disclaimer 59

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 9
  • Table 2: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 9
  • Table 3: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, 2015-2020 11
  • Table 4: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, 2021-2025 11
  • Table 5: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 13
  • Table 6: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 14
  • Table 7: Cardiac Assist Devices Market, United States, Volume (Units), 2015-2020 16
  • Table 8: Cardiac Assist Devices Market, United States, Volume (Units), 2021-2025 16
  • Table 9: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), 2015-2020 18
  • Table 10: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), 2021-2025 18
  • Table 11: Ventricular Assist Devices Market, United States, Volume (Units), 2015-2020 20
  • Table 12: Ventricular Assist Devices Market, United States, Volume (Units), 2021-2025 21
  • Table 13: Cardiac Assist Devices Market, United States, Average Price ($), 2015-2020 22
  • Table 14: Cardiac Assist Devices Market, United States, Average Price ($), 2021-2025 23
  • Table 15: Cardiac Assist Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 24
  • Table 16: Cardiac Assist Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017 26
  • Table 17: Cardiac Assist Devices Market Pipeline Products 29
  • Table 18: Audax Private Equity Acquires Belmont Instrument 30
  • Table 19: Ariste Medical Raises USD0.3 Million in Financing 31
  • Table 20: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 56

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 8
  • Figure 2: Intra-Aortic Balloon Pumps Market, United States, Revenue ($m), USD Constant, 2015-2025 10
  • Figure 3: Ventricular Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 12
  • Figure 4: Cardiac Assist Devices Market, United States, Volume (Units), 2015-2025 15
  • Figure 5: Intra-Aortic Balloon Pumps Market, United States, Volume (Units), 2015-2025 17
  • Figure 6: Ventricular Assist Devices Market, United States, Volume (Units), 2015-2025 19
  • Figure 7: Cardiac Assist Devices Market, United States, Company Share (%) 2017 25
Back to Top